Sam Kings

Sam’s experience includes advising:

• Sigma Healthcare on its proposed $8.8 billion reverse takeover and ASX listing of Chemist Warehouse.

• TPG on its acquisition of InvoCare for approximately $1.8 billion.

• OZ Minerals in relation to the $9.6 billion acquisition by BHP by scheme of arrangement.

• Alludo on its proposed acquisition of Nitro Software by concurrent scheme and takeover for $530 million.

• Atlas Arteria on its response to IFM’s acquisition of a 19% interest (valuing the company at over $7.6 billion) and on its proposed US$2 billion acquisition of Chicago Skyway and associated $3 billion equity raising.

• Tabcorp on the $10 billion demerger of its lotteries business, The Lottery Corporation.

• QSuper on its participation in the $24 billion acquisition of Sydney Airport by Sydney Aviation Alliance by scheme of arrangement.

• Various private funds including KKR, TPG, Livingbridge, Navis Capital Partners, Viburnum Funds and Baring Vostok Capital Partners in relation to corporate transactions.

• Amcor on its US$6.8 billion merger with Bemis Company Inc and redomiciliation to Jersey with an NYSE listing via scheme of arrangement (valued at $17.7 billion).

• Healthscope on its $4.4 billion scheme of arrangement and simultaneous takeover bid by Brookfield.

• OZ Minerals on its $440 million acquisition of Avanco Resources by takeover bid.

• Aconex in relation to the $1.6 billion acquisition by Oracle by scheme of arrangement.